For example, HER2-driven breast cancer progression relies partly on NF-κB activation [248], whereas EGFR expression itself is transcriptionally regulated by NF-κB [249], highlighting its multifaceted role in growth signaling. Here, NFKB1 is linked to breast carcinoma.